The differential diagnosis of BL includes HGBCL/DLBCL with MYC and BCL2 gene rearrangements (either de novo or as a transformation of a follicular lymphoma), B-lymphoblastic leukemia/lymphoma and high-grade/large B-cell lymphoma with 11q aberrations. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.